Ads
related to: myeloid leukemia cells- Efficacy
Durable Complete Remissions
for R/R AML Patients.
- Access & Resources
Support is Available for
You and Your Patients.
- Safety
Learn More About Well Characterized
Safety Profile.
- Mechanism of Action
Inhibits Mutant IDHI and
Restores Myeloblast Differentiation
- Efficacy
Search results
Is Geron Stock a Buy Following Its First New Drug Approval?
Motley Fool via Yahoo Finance· 5 hours agoAround 30% of MDS cases progress to acute myeloid leukemia. Even for patients who don't progress to...
Valrubicin-loaded immunoliposomes: A new technology to fight hematological cancer
Medical Xpress· 2 days agoValrubicin, a lipophilic chemical molecule similar to daunorubicin, has primarily been used in the treatment of bladder cancer. An article recently published in Cell Death ...
Cancer-fighting antibodies inject chemo directly into tumor cells, upping effectiveness
NBC NEWS· 6 days agoThe approach isn’t entirely new: The first antibody drug conjugate was approved by the Food and Drug...
MD Anderson Research Highlights for June 5, 2024 | Newswise
Newswise· 3 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These
'Smart warheads' of cancer: Experts' excitement for treatment approach grows
Becker’s Hospital Review· 5 days agoCancer experts are increasingly optimistic about the potential for antibody-drug conjugates to become a standard treatment approach. The therapies involve attaching chemotherapy to an antibody ...
Steps To-Marrow: Grandmother walks hundreds of miles to raise donor awareness
The Wenatchee World· 3 days agoJeana Moore, 71, is not singing “I’m Gonna Be,” but she is walking hundreds of miles, thousands one...
How a protein component of nuclear pore complexes | Newswise
Newswise· 3 days agoNuclear pore complexes (NPCs) are channels composed of multiple proteins that ferry molecules in and...
HUTCHMED Initiates Phase I Trial of Menin Inhibitor HMPL-506 in Patients with Hematological...
Benzinga· 2 days agoHONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated Phase I clinical trial of its menin
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Zacks via Yahoo Finance· 1 day agoData from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective...
FDA Approves Imetelstat for Rare Low-Risk Blood Cancer
Medscape· 1 day agoThe approval for the first-in-class agent is "potentially practice changing" given the lack of treatment options for transfusion-dependent lower-risk MDS patients.
Ads
related to: myeloid leukemia cells
